Fresenius SE & CO. KGAA Detailed Consensus >> Group
Consensus as of: 2024-05-02

Please kindly note:

  1.  Fresenius Medical Care is now accounted for at equity under IAS 28 and is shown in the line “Result from FME (FY 2024+: Result from Equity Method FME; 32% of FME net income before special items)”. FY 23 Actuals in the same line reflect the net income from FME operations deconsolidated under IFRS 5.
  2.  We fully exclude the Eugin fertility services segment for Q1 2024 and FY 2024 respectively. The divesture was completed on 31st of January 2024.
  3.  Consensus estimates are before special items.

KPI[EUR m]Q1 2023FY 2023Q1 2024 EFY 2024 EFY 2025 E
RevenueNumber of Estimates111212
RevenueHighest5,774.523,300.524,602.5
RevenueConsensus (Mean)5,546.022,299.05,688.222,940.524,043.8
RevenueMedian5,692.822,929.624,035.4
RevenueLowest5,551.322,440.823,368.1
Organic revenue growth (in %)Number of Estimates799
Organic revenue growth (in %)Highest5.35.75.7
Organic revenue growth (in %)Consensus (Mean)6.55.54.94.74.7
Organic revenue growth (in %)Median5.04.94.7
Organic revenue growth (in %)Lowest4.13.03.0
EBITNumber of Estimates111212
EBITHighest645.72,571.42,877.9
EBITConsensus (Mean)554.02,262.0606.02,437.12,700.3
EBITMedian600.42,422.32,705.1
EBITLowest591.02,335.02,527.0
EBIT margin (in %)Number of Estimates111212
EBIT margin (in %)Highest11.211.111.7
EBIT margin (in %)Consensus (Mean)10.010.110.710.611.2
EBIT margin (in %)Median10.610.611.3
EBIT margin (in %)Lowest10.410.410.5
Net interestNumber of Estimates91111
Net interestHighest-81.0-410.0-371.6
Net interestConsensus (Mean)-87.0-418.0-103.2-428.4-414.9
Net interestMedian-104.7-427.0-407.6
Net interestLowest-117.1-468.6-474.9
TaxesNumber of Estimates91111
TaxesHighest-114.7-462.9-496.3
TaxesConsensus (Mean)-114.0-522.0-126.0-506.3-580.7
TaxesMedian-124.5-501.0-573.0
TaxesLowest-141.2-549.8-669.0
Tax rate in %Number of Estimates91111
Tax rate in %Highest26.527.428.4
Tax rate in %Consensus (Mean)24.428.325.025.125.3
Tax rate in %Median25.025.525.5
Tax rate in %Lowest23.323.322.2
Net income from continuing operationsNumber of Estimates101212
Net income from continuing operationsHighest4241,6061,840
Net income from continuing operationsConsensus (Mean)3531,3223781,5081,710
Net income from continuing operationsMedian3751,5011,722
Net income from continuing operationsLowest3591,4441,579
Non-controlling interest in continuing operationsNumber of Estimates101111
Non-controlling interest in continuing operationsHighest-10.2-56.3-60.0
Non-controlling interest in continuing operationsConsensus (Mean)-12.0-60.0-16.6-70.9-75.9
Non-controlling interest in continuing operationsMedian-16.2-72.2-78.0
Non-controlling interest in continuing operationsLowest-25.0-85.0-87.6
Net income ex FMENumber of Estimates101111
Net income ex FMEHighest408.51,546.41,780.4
Net income ex FMEConsensus (Mean)341.01,262.0361.81,431.71,636.6
Net income ex FMEMedian355.71,429.11,640.1
Net income ex FMELowest344.21,371.91,492.0
EPS (in EUR) ex FMENumber of Estimates91010
EPS (in EUR) ex FMEHighest0.732.753.16
EPS (in EUR) ex FMEConsensus (Mean)0.612.240.642.542.91
EPS (in EUR) ex FMEMedian0.632.532.92
EPS (in EUR) ex FMELowest0.612.442.65
Result from FME (FY 2024+: Result from Equity Method FME; 32% of FME net income before special items)Number of Estimates899
Result from FME (FY 2024+: Result from Equity Method FME; 32% of FME net income before special items)Highest60.8271.8377.8
Result from FME (FY 2024+: Result from Equity Method FME; 32% of FME net income before special items)Consensus (Mean)48.0243.051.1243.1321.0
Result from FME (FY 2024+: Result from Equity Method FME; 32% of FME net income before special items)Median50.7255.2325.0
Result from FME (FY 2024+: Result from Equity Method FME; 32% of FME net income before special items)Lowest38.4156.6244.0
Net income attributable to FSENumber of Estimates81010
Net income attributable to FSEHighest425.61,703.02,058.7
Net income attributable to FSEConsensus (Mean)389.01,505.0408.61,663.31,969.3
Net income attributable to FSEMedian413.11,685.31,968.2
Net income attributable to FSELowest384.01,594.01,875.9
EPS (in EUR)Number of Estimates81010
EPS (in EUR)Highest0.763.023.66
EPS (in EUR)Consensus (Mean)0.692.670.732.953.49
EPS (in EUR)Median0.732.973.49
EPS (in EUR)Lowest0.682.833.33
Average number of ordinary shares (in million)Number of Estimates111212
Average number of ordinary shares (in million)Highest563.24564.74566.24
Average number of ordinary shares (in million)Consensus (Mean)563.24563.24563.24563.48563.68
Average number of ordinary shares (in million)Median563.24563.24563.24
Average number of ordinary shares (in million)Lowest563.24563.08563.08
Disclaimer

This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.